BUY Balaji Amines Ltd — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))15 May 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Balaji Amines Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The press release is available on the company's website.
NSE · Press Release·14 May · 4d ago
Balaji Amines Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NSE · Outcome of Board Meeting·13 May · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Balaji Amines
- BUY — Siddharth Rai Mangala24 Sept 2026 · ~2 weeks · target ₹2,350 · SL hit
- BUY — Choice Broking7 Sept 2026 · ~2 weeks · target ₹2,700 · SL hit
- BUY — Siddharth Rai Mangala4 Sept 2026 · ~2 weeks · target ₹2,625 · Target hit
- BUY — Ashish Kyal, Waves Strategy Advisors4 Sept 2026 · ~2 weeks · target ₹2,630 · SL hit
- BUY — Sudeep Shah, SBICAP Securities24 Aug 2026 · ~2 weeks · target ₹2,310 · Target hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

